Unveiling quality of clinical trial in China: from concern to confirmation

• Huiyao Huang,
• Yiru Hou,
• Hong Fang,
• Ling Xu,
• Yue Yu,
• Huifang Zhang,
• Jing Zhang,
• Yu Tang,
• Gongtao Lan,
• Wenbao Zhang,
• Ning Li

Affiliations

Huiyao Huang

Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing P. R. China

Yiru Hou

Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing P. R. China

Hong Fang

Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing P. R. China

Ling Xu

Department of Quality Medicine Boehringer Ingelheim (China) Investment Co Ltd Shanghai P. R. China

Yue Yu

Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing P. R. China

Huifang Zhang

Department of Quality Medicine Boehringer Ingelheim (China) Investment Co Ltd Shanghai P. R. China

Jing Zhang

Department of Clinical Development Quality Pfizer Research and Development (China) Beijing P. R. China

Yu Tang

Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing P. R. China

Gongtao Lan

Department of Drug Registration National Medical Products Administration Beijing P. R. China

Wenbao Zhang

Bureau of Medical Administration National Health Commission Beijing P. R. China

Ning Li

Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing P. R. China